Selective neuronal degeneration in Huntington's disease

被引:117
作者
Cowan, Catherine M. [1 ]
Raymond, Lynn A. [1 ]
机构
[1] Univ British Columbia, Dept Psychiat, Div Neurosci, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada
来源
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 75 | 2006年 / 75卷
关键词
D O I
10.1016/S0070-2153(06)75002-5
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Huntington's disease (HD) is a progressive neurodegenerative disorder that generally begins in middle age with abnormalities of movement, cognition, personality, and mood. Neuronal loss is most marked among the medium-sized projection neurons of the dorsal striatum. HD is an autosomal dominant genetic disorder caused by a CAG expansion in exon 1 of the HD gene, encoding an expanded polyglutamine (polyQ) tract near the N-terminus of the protein huntingtin. Despite identification of the gene mutation more than a decade ago, the normal function of this ubiquitously expressed protein is still under investigation and the mechanisms underlying selective neurodegeneration in HD remain poorly understood. Detailed postmortem analyses of brains of HD patients have provided important clues, and HD transgenic and knock-in mouse models have facilitated investigations into potential pathogenic mechanisms. Subcellular fractionation and immunolocalization studies suggest a role for huntingtin in organelle transport, protein trafficking, and regulation of energy metabolism. Consistent with this, evidence from vertebrate and invertebrate models of HD indicates that expression of the polyQ-expanded form of huntingtin results in early impairment of axonal transport and mitochondrial function. As well, alteration in activity of the N-methyl-d-aspartate (NMDA) type glutamate receptor, which has been implicated as a main mediator of excitotoxic neuronal death, especially in the striatum, is an early effect of mutant huntingtin. Proteolysis and nuclear localization of huntingtin also occur relatively early, while formation of ubiquitinated aggregates of huntingtin and transcriptional dysregulation occur as late effects of the gene mutation. Although each of these processes may contribute to neuronal loss in HD, here we review the data to support a strong role for NMDA receptor (NMDAR)-mediated excitotoxicity and mitochondrial dysfunction in conferring selective neuronal vulnerability in HD. © 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:25 / 71
页数:47
相关论文
共 217 条
[11]   CAG EXPANSION AFFECTS THE EXPRESSION OF MUTANT HUNTINGTIN IN THE HUNTINGTONS-DISEASE BRAIN [J].
ARONIN, N ;
CHASE, K ;
YOUNG, C ;
SAPP, E ;
SCHWARZ, C ;
MATTA, N ;
KORNREICH, R ;
LANDWEHRMEYER, B ;
BIRD, E ;
BEAL, MF ;
VONSATTEL, JP ;
SMITH, T ;
CARRAWAY, R ;
BOYCE, FM ;
YOUNG, AB ;
PENNEY, JB ;
DIFIGLIA, M .
NEURON, 1995, 15 (05) :1193-1201
[12]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[13]   Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellular in situ hybridization study [J].
Augood, SJ ;
Faull, RLM ;
Love, DR ;
Emson, PC .
NEUROSCIENCE, 1996, 72 (04) :1023-1036
[14]  
BEAL MF, 1991, J NEUROSCI, V11, P1649
[15]   Mitochondria take center stage in aging and neurodegeneration [J].
Beal, MF .
ANNALS OF NEUROLOGY, 2005, 58 (04) :495-505
[16]   REPLICATION OF THE NEUROCHEMICAL CHARACTERISTICS OF HUNTINGTONS-DISEASE BY QUINOLINIC ACID [J].
BEAL, MF ;
KOWALL, NW ;
ELLISON, DW ;
MAZUREK, MF ;
SWARTZ, KJ ;
MARTIN, JB .
NATURE, 1986, 321 (6066) :168-171
[17]   AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1995, 38 (03) :357-366
[18]  
BEAL MF, 1993, J NEUROSCI, V13, P4181
[19]   Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice:: exclusion of proteasome activator REGγ as a therapeutic target [J].
Bett, JS ;
Goellner, GM ;
Woodman, B ;
Pratt, G ;
Rechsteiner, M ;
Bates, GP .
HUMAN MOLECULAR GENETICS, 2006, 15 (01) :33-44
[20]   Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice [J].
Bibb, JA ;
Yan, Z ;
Svenningsson, P ;
Snyder, GL ;
Pieribone, VA ;
Horiuchi, A ;
Nairn, AC ;
Messer, A ;
Greengard, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6809-6814